Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jonsson

Showing results (171-180 of 216) with videos related to

Pageof 22
Sort By:
Health Policy (Amsterdam, Netherlands)|February 6, 1998
International collaboration in health technology assessment: a study of technologies used in management of osteoporosisD Hailey, D Marshall, L Sampietro-Colom, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 31, 1997
BRCA2 mutation in Icelandic prostate cancer patientsS Sigurdsson, S Thorlacius, J Tomasson, et al.
Radiology|February 7, 2001
Rectal carcinoma: double-contrast MR imaging for preoperative stagingN O Wallengren, S Holtås, A Andrén-Sandberg, et al.
ACS Nano|August 27, 2011
Gyroid nanoporous membranes with tunable permeabilityLi Li, Lars Schulte, Lydia D Clausen, et al.
Archives of Biochemistry and Biophysics|June 28, 2000
Characterization and functional analysis of two common human cytochrome P450 1B1 variantsR A McLellan, M Oscarson, M Hidestrand, et al.
Anti-Cancer Drugs|March 29, 2001
A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828S B Hassan, M de la Torre, P Nygren, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 3, 2017
A health economic simulation model for the clinical management of osteoporosisE Jonsson, A Hansson-Hedblom, Ö Ljunggren, et al.
Cancer Research|December 3, 1999
CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivoP J Hjarnaa, E Jonsson, S Latini, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow-fibre model in ratsE Jonsson, L E Friberg, M O Karlsson, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 28, 2022
A One Health real-time surveillance system for nowcasting <i>Campylobacter</i> gastrointestinal illness outbreaks, Norway, week 30 2010 to week 11 2022David Swanson, Clemence Koren, Petter Hopp, et al.
Pageof 22

Showing results (171-180 of 216) with videos related to

Sort By:
Pageof 22
Health Policy (Amsterdam, Netherlands)|February 6, 1998
International collaboration in health technology assessment: a study of technologies used in management of osteoporosisD Hailey, D Marshall, L Sampietro-Colom, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 31, 1997
BRCA2 mutation in Icelandic prostate cancer patientsS Sigurdsson, S Thorlacius, J Tomasson, et al.
Radiology|February 7, 2001
Rectal carcinoma: double-contrast MR imaging for preoperative stagingN O Wallengren, S Holtås, A Andrén-Sandberg, et al.
ACS Nano|August 27, 2011
Gyroid nanoporous membranes with tunable permeabilityLi Li, Lars Schulte, Lydia D Clausen, et al.
Archives of Biochemistry and Biophysics|June 28, 2000
Characterization and functional analysis of two common human cytochrome P450 1B1 variantsR A McLellan, M Oscarson, M Hidestrand, et al.
Anti-Cancer Drugs|March 29, 2001
A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828S B Hassan, M de la Torre, P Nygren, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 3, 2017
A health economic simulation model for the clinical management of osteoporosisE Jonsson, A Hansson-Hedblom, Ö Ljunggren, et al.
Cancer Research|December 3, 1999
CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivoP J Hjarnaa, E Jonsson, S Latini, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow-fibre model in ratsE Jonsson, L E Friberg, M O Karlsson, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 28, 2022
A One Health real-time surveillance system for nowcasting <i>Campylobacter</i> gastrointestinal illness outbreaks, Norway, week 30 2010 to week 11 2022David Swanson, Clemence Koren, Petter Hopp, et al.
Pageof 22